JANE STREET GROUP, LLC - THERAVANCE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B956. A total of 4 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$143,220
-25.8%
13,200
-23.3%
0.00%–
Q4 2022$192,984
-6.8%
17,200
-15.7%
0.00%–
Q3 2022$207,000
-28.6%
20,400
-36.2%
0.00%–
Q2 2022$290,000–32,000–0.00%–
 Download
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 85,900$871,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 20,700$210,0000.00%
JANE STREET GROUP, LLC 20,400$207,0000.00%
View complete list of THERAVANCE BIOPHARMA INC shareholders